Antimicrobial Agents and Chemotherapy: Combination PI-Containing Regimen for HIV-Infected, Treatment-Experienced Patients

Combination PI-Containing Regimen for HIV-Infected, Treatment-Experienced Patients
Speaker: Robert Schooley, MD, Head of Infectious Diseases and Professor of Medicine, University of Colorado, Denver, Colorado.
Based on a preliminary 24-week analysis, amprenavir 600 mg (Agenerase, GlaxoSmithKline)/ritonavir 100 mg (Norvir drug, Abbott) twice daily might be a better treatment regimen than amprenavir 900 mg/ritonavir 100 mg twice daily because the lower amprenavir dose results in a similar efficacy, a lower incidence of adverse events and patient withdrawals, and a lower pill burden.










